The Health Security Agency and NHS England have published a letter providing information regarding the forthcoming expansion of the eligibility criteria for the NHS older adults Respiratory syncytial virus (RSV) vaccination programme. The letter is aimed at those responsible for commissioning and operationally delivering the national NHS RSV older adults vaccination programme in England.
From 01 September 2026, the eligibility criteria will expand further to include adults aged 65 to 74 years in certain clinical at risk groups as advised by the Joint Committee on Vaccination and Immunisation (JCVI):
- chronic respiratory disease
- immunosuppression due to disease or treatment